TRMT6 and urinary bladder cancer: Specifically, the removal of TRMT6/TRMT61A resulted in decreased mRNA levels of the conventional transcription factor UPR ATF6-associated targets, leading to a reduction in bladder cancer cell proliferation and stress resistance (Monshaugen et al., 2024).